BACKGROUND: Congenital bronchoesophageal fistula (BEF) is a rare communicating bronchopulmonary foregut malformation (CBPFM) characterized by an abnormal connection between the esophagus and a bronchial segment or lung tissue. While esophageal atresia (EA), with or without tracheoesophageal fistula, occurs in approximately 2-3 per 10,000 live births, EA associated with CBPFM/congenital BEF is far rarer, with no established population-based incidence and only several dozen reported CBPFM cases in the literature. Most congenital BEFs present in childhood or adulthood with chronic, nonspecific respiratory symptoms and recurrent infections, whereas neonatal presentations are typically linked to major associated anomalies such as EA. Importantly, complex neonatal constellations-particularly those combining EA with bronchial atresia and a severely hypoplastic, non-aerated lung-may represent an atypical CBPFM variant that does not fit neatly within traditional BEF classification schemes. CASE PRESENTATION: We report a premature Arab female infant born at 32 weeks gestation who presented with respiratory distress, copious oral secretions, and radiographic features of EA with complete right hemithorax opacification and mediastinal shift to the right on a chest X-ray (CXR). After initial stabilization, a gastrostomy tube was inserted. Contrast studies via the gastrostomy tube and computed tomography angiography (CTA) revealed EA with a fistulous communication between the distal esophagus and right bronchial structures, along with a severely hypoplastic right lung. On day 33 of life, the patient underwent surgery. Intraoperative findings confirmed a fistula between the atretic right main bronchus and the lower esophagus, with a nonfunctioning right lung. Definitive EA repair and right pneumonectomy were performed. Histopathology revealed bronchial atresia involving the right main bronchus with right pulmonary hypoplasia. The postoperative course was complicated by pneumothorax, pneumomediastinum, sepsis, and persistent anastomotic leakage, and was managed conservatively with drainage, antimicrobial/antifungal therapy, and prolonged total parenteral nutrition. Serial contrast studies confirmed gradual leak resolution, and oral feeding was started by postoperative day 87. On follow-up, the infant initially maintained oxygen saturation and stable vital signs in room air without respiratory support; however, feeding advancement was complicated by recurrent vomiting and suspected delayed gastric emptying/gastroparesis. Despite combined parenteral and enteral nutrition and a trial of continuous orogastric tube feeding, the infant later developed severe septic shock requiring intravenous antibiotics and ventilatory support. The septic shock was refractory, and the patient died at 5 months of chronological age, corresponding to approximately 3 months corrected age. CONCLUSION: This case represents an atypical congenital BEF variant in which EA coexists with a distal esophageal fistula to an atretic right main bronchus and a severely hypoplastic, non-aerated right lung, highlighting a classification-challenging phenotype. It underscores the crucial role of early targeted imaging in neonates with suspected EA and unilateral lung hypoplasia/atresia. Advanced imaging enables accurate diagnosis and guides surgical planning, while the fatal follow-up course highlights the clinical vulnerability of these patients and the need for careful long-term multidisciplinary monitoring.
Background: Severity of illness assessment tools are utilized to triage critically-ill patients and provide a valuable inputs to the healthcare provider to decide the type and intensity of treatment or interventions. Objective: The aim of this study was to evaluate the discriminatory capabilities of Acute Physiology And Chronic Health Evaluation II (APACHE II) score in the prediction of Intensive care units (ICUs) mortality among patients with sepsis admitted to the ICU. Methods: Records of patients with sepsis admitted to ICUs were retrospectively reviewed. Discriminatory performance of APACHE II score was assessed by using the receiver operating characteristic's (ROC's) area under the curve (AUC). Results: The mean±SD of APACHE II score was 27.1±8.4. APACHE II score demonstrated a very good discriminatory performance with an accuracy rate of 75% and an AUC-ROC 0.80 (95%CI: 0.74 - 0.85) at an optimal cutoff of 26. APACHE II score was found to be correlated with ICU mortality with a correlation coefficient of (0.52). ICU mortality was significantly higher in patients with APACHE II score ≥26. Conclusion: This study revealed that the discriminatory performance of APACHE II score in predicting ICU mortality in patient with sepsis was very good. These findings can have potential clinical implications in the identification and management of patients with sepsis admitted to the ICU.
APACHE II scoresepsisICU mortalitymortality prediction
BACKGROUND: Neonatal sepsis, a leading cause of newborn mortality, arises from systemic infections due to an immature immune system. Its subtle early symptoms complicate timely diagnosis. Hematological parameters act as an indicator for early detection, crucial for prompt treatment, improving prognosis, and are not a challenging or cumbersome process. AIM: The primary objective was to evaluate the significance of hematological parameters including red blood cell (RBC), WBC, and platelet counts in the context of neonatal sepsis. METHODS: This hospital-based cohort study examined 73 neonates admitted to the neonatal intensive care unit (NICU) of Saveetha Medical College and Hospital, Chennai, India during the period of January 2023 to March 2024. All the new born patients were presented with blood culture-confirmed septicemia. RESULTS: The investigation identified Klebsiella pneumoniae as the most prevalent etiological agent (26.02%), followed by Coagulase-Negative Staphylococci (CONS) and Acinetobacter baumannii (both 8.2%). Alterations in total leukocyte count and hematocrit were observed in 57% and 68.1% of cases, respectively, providing a prompt indication of infection status. Subsequent analyses revealed prominent leukocytosis, hematocrit irregularities, and thrombocytopenia, frequently manifesting in septic cases and demonstrating potential as early markers for neonatal sepsis. CONCLUSION: The study highlights the diagnostic value of hematological alterations, such as leukocytosis and hematocrit distortion, in the prompt identification of septicemia among neonates. Based on the findings, it is recommended that routine hematological screening to be integrated as a standard component of neonatal sepsis diagnosis for rapid investigation of neonatal sepsis.
Advanced Health Science and Technology Journal · مجلد 1 (1) · 2-8
Abstract Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, carrying high global mortality. Timely diagnosis and management are critical, with modern approaches emphasizing organ dysfunction (measured by Sequential Organ Failure Assessment score) over older systemic inflammatory response syndrome criteria. Biomarkers such as procalcitonin and lactate aid in distinguishing infection severity and guiding resuscitation. The current guidelines stress rapid fluid administration, vasopressors for blood pressure stabilization, and antibiotic delivery within one hour – delays significantly worsen outcomes. This scoping review analyzes 39 studies (2015–2024) on sepsis management, revealing diverse interventions. Protocol-driven strategies (e.g. Sepsis six and nurse-led protocols) improved early recognition and bundle compliance but showed inconsistent mortality reduction. Fluid management studies highlighted the risks of both under-resuscitation and overload, with balanced crystalloids potentially offering renal benefits over saline. Antibiotic stewardship, guided by procalcitonin, reduced unnecessary exposure, although operational challenges hindered timely administration. Diagnostic tools such as point-of-care lactate and coagulation markers enhanced decision-making but faced variability in the real-world utility. intensive care unit structure (open vs. closed) had minimal impact compared to protocol adherence and clinician expertise. Specialized interventions (e.g., labor induction in septic pregnancies) underscored the need for context-specific approaches. Despite advances, critical gaps persist: (1) mortality benefits lag behind process improvements, (2) biomarker access disparities limit global applicability, and (3) fluid/antibiotic personalization remains underexplored. Future research must address these challenges through pragmatic trials and implementation science.
Acute kidney injury (AKI) is a devastating consequence of sepsis, accompanied by high mortality rates. It was suggested that inflammatory pathways are closely linked to the pathogenesis of lipopolysaccharide (LPS)-induced AKI. Inflammatory signaling, including PCSK9, HMGB1/RAGE/TLR4/MYD88/NF-κB, NLRP3/caspase-1 and Fractalkine/CX3CR1 are considered major forerunners in this link. Alirocumab, PCSK9 inhibitor, with remarkable anti-inflammatory features. Accordingly, this study aimed to elucidate the antibacterial effect of alirocumab against E. coli in vitro. Additionally, evaluation of the potential nephroprotective effects of alirocumab against LPS-induced AKI in rats, highlighting the potential underlying mechanisms involved in these beneficial actions. Thirty-six adult male Wistar rats were assorted into three groups (n=12). Group I; was a normal control group, whereas sepsis-mediated AKI was induced in groups II and III through single-dose intraperitoneal injection of LPS on day 16. In group III, animals were given alirocumab. The results revealed that LPS-induced AKI was mitigated by alirocumab, evidenced by amelioration in renal function tests (creatinine, cystatin C, KIM-1, and NGAL); oxidative stress biomarkers (Nrf2, HO-1, TAC, and MDA); apoptotic markers and renal histopathological findings. Besides, alirocumab pronouncedly hindered LPS-mediated inflammatory response, confirmed by diminishing HMGB1, TNF-α, IL-1β, and caspase-1 contents; the gene expression of PCSK9, RAGE, NF-ᴋB and Fractalkine/CX3CR1, along with mRNA expression of TLR4, MYD88, and NLRP3. Regarding the antibacterial actions, results showed that alirocumab displayed potential anti-bacterial activity against pathogenic gram-negative E. coli. In conclusion, alirocumab elicited nephroprotective activities against LPS-induced AKI via modulation of Nrf2/HO-1, PCSK9, HMGB1/RAGE/TLR4/MYD88/NF-ᴋB/NLRP3/Caspase-1, Fractalkine/CX3R1 and apoptotic axes.
Clinical Case Reports · مجلد 12 (11) · e9378-e9378
Key Clinical Message: It is important to consider the diagnosis of Sump syndrome in patients with a history of open cholecystectomy, particularly in those who migrate from developing countries where alternative biliary interventions may be limited. The presentation may range from acute severe, mimicking acute ascending cholangitis, to chronic recurrent abdominal pain without evidence of inflammation. Management is a case-by-case decision, with principal management aims to decompress the biliary tract and address any underlying sepsis. Abstract: Sump syndrome is a rare and often long-term complication of choledochoduodenostomy (CDD). The presentation and severity are variable, and management should be tailored to each patient based on several factors. Herein, we report three cases of sump syndrome, each demonstrating unique diagnostic dilemmas and therapeutic modalities. Case I describes a woman presenting with acute cholangitis, managed with percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP). Case II illustrates a similar presentation complicated by myocardial infarction, necessitating urgent biliary decompression via PTC and subsequent unsuccessful endoscopic stenting. Case III highlights the diagnostic difficulty in a stable patient with inconclusive diagnostic imaging. This case series emphasizes the importance of considering sump syndrome diagnosis in patients with a history of CDD or open cholecystectomy, especially in elderly patients and those who come from regions where alternative biliary interventions may be limited.
Introduction Neonatal sepsis is defined as a systemic illness caused by bacteria, viruses, or fungi, characterized by hemodynamic abnormalities and clinical findings that result in morbidity and mortality. Neonatal morbidity and mortality are significantly influenced by neonatal sepsis. Causative pathogens and antimicrobial sensitivity profiles have changed over time, with significant geographic variation. Aim To determine the characteristics and associated risk factors of sepsis among neonates admitted into neonatal intensive care units (NICU) in Maternity and Children Hospital, AlAhsa, Saudi Arabia. Methodology An institution-based retrospective cross-sectional study was conducted among neonates who were admitted to the neonatal intensive care unit from January 2022 to December 2023 at the Maternity and Children Hospital, AlAhsa, Saudi Arabia. All neonates born with clinically diagnosed sepsis and positive culture were included in this study. Results This study included 134 neonates with a culture-proven diagnosis of neonatal sepsis during the study period. There were 23 (17.2%) cases of early-onset sepsis (EOS) and 111 (82.8%) cases of late-onset sepsis (LOS). Compared to late-onset sepsis (18.8%), Pseudomonas aeruginosa is more common in early-onset sepsis (33.3%). In cases of early-onset sepsis, Escherichia coli is isolated more often (33.3%) than in cases of late-onset (9.4%). Neonatal sepsis mortality is higher in LOS (25 [22.5%]) than in EOS (3 [13%]). Neonates with extremely preterm birth weight, gram-negative sepsis, and thrombocytopenia have a significantly higher mortality rate (p=<0.05). Conclusion In order to lower the risk among newborns, policymakers and/or managers will benefit from the information provided by the assessment of the prevalence, clinical outcomes, and risk factors for neonatal sepsis. Furthermore, developing hospital-based care strategies requires an understanding of the microorganisms that cause infections among neonates.
In the management of sepsis, providing adequate empiric antimicrobial therapy is one of the most important pillars of sepsis management. Therefore, it is important to evaluate the adequacy of empiric antimicrobial therapy (EAMT) in sepsis patients admitted to intensive care units (ICU) and to identify the determinants of inadequate EAMT. The aim of this study was to evaluate the adequacy of empiric antimicrobial therapy in patients admitted to the ICU with sepsis or septic shock, and the determinants of inadequate EAMT. The data of patients admitted to the ICU units due to sepsis or septic shock in two tertiary healthcare facilities in Al-Madinah Al-Munawwarah were retrospectively reviewed. The current study used logistic regression analysis and artificial neural network (ANN) analysis to identify determinants of inadequate empiric antimicrobial therapy, and evaluated the performance of these two approaches in predicting the inadequacy of EAMT. The findings of this study showed that fifty-three per cent of patients received inadequate EAMT. Determinants for inadequate EAMT were APACHE II score, multidrug-resistance organism (MDRO) infections, surgical history (lower limb amputation), and comorbidity (coronary artery disease). ANN performed as well as or better than logistic regression in predicating inadequate EAMT, as the receiver operating characteristic area under the curve (ROC-AUC) of the ANN model was higher when compared with the logistic regression model (LRM): 0.895 vs. 0.854. In addition, the ANN model performed better than LRM in predicting inadequate EAMT in terms of classification accuracy. In addition, ANN analysis revealed that the most important determinants of EAMT adequacy were the APACHE II score and MDRO. In conclusion, more than half of the patients received inadequate EAMT. Determinants of inadequate EAMT were APACHE II score, MDRO infections, comorbidity, and surgical history. This provides valuable inputs to improve the prescription of empiric antimicrobials in Saudi Arabia going forward. In addition, our study demonstrated the potential utility of applying artificial neural network analysis in the prediction of outcomes in healthcare research.
sepsisseptic shockempiric antimicrobial therapyintensive care unit
International Journal of Community Medicine and Public Health · مجلد 11 (1) · 521-525
The use of biomarkers in emergency situations represents a change in modern healthcare. This review examines their impact in emergencies focusing on how they improve the accuracy of diagnoses, provide insights into prognosis and aid in treatment decisions. Notably troponins (I and T) are effective in diagnosing myocardial infarction enabling targeted interventions and risk assessment for cardiovascular emergencies. In cases of sepsis procalcitonin helps distinguish infections and influences decisions about therapy, which is crucial for global efforts against resistance. S100B, a biomarker used in emergencies assists in prioritizing cases of brain injury. To prevent harm, serum markers like creatinine and cystatin C guide interventions for hepatic emergencies. For trauma and hematological emergencies D dimer and lactate provide prognostic information. Ongoing research is exploring biomarkers well as the integration of artificial intelligence offering promising advancements for the future. The clinical significance of biomarkers highlights a commitment to approaches that contribute to the ever-evolving field of emergency medicine and ultimately enhance patient care.
Microbes and Infectious Diseases /Microbes and Infectious Diseases · مجلد 0 (0) · 0-0
Background: This study designed to evaluate the level of IL-27 in umbilical cord blood and the possibility of its use as a predictor for diagnosis of Early Onset Neonatal Sepsis (EONS). Methods: This observational analytic study was conducted by enrolling newborn infants born to pregnant women with antenatal risk factors for sepsis. The infection group that included both suspected and confirmed EONS occurred ≤72 hours after delivery compared to non-infection group. Blood samples were collected from the umbilical artery after cord clamping for biomarkers detection and after 24 hours from venous blood. The concentrations of IL-27 and procalcitonin (PCT) were measured by sandwich ELISA assay. Results: A total of 124 neonates were enrolled, 48 (38.7%) neonates were identified in infection group either suspected or confirmed EONS. A significantly higher levels of IL-27 was found in cord blood of babies in the infection group (p<0.01). At 24h after birth, the IL-27 continued to show significantly higher levels in infection group (p<0.01) compared to non-infection group. The IL-27 showed an increased risk of EONS with an odds ratio of 9.13 and p<0.01. The IL-27 through ROC curve analysis showed a better performance in distinguishing neonates with true infection from neonates without infection. A combined performance of IL-27 with PCT in the cord blood and at 24 hours of life showed greater prediction of EONS with p <0.01 for each. Conclusion: The IL-27 level in the blood of the umbilical cord may offer a significant predictive tool for EONS either alone or more significantly in combination with PCT.
Frontiers in Cardiovascular Medicine · مجلد 9 · 916920-916920
Background: Ovarian vein thrombosis (OVT) is an uncommon condition, occurring in ~1 in every 600-2,000 pregnancies. It is associated with various conditions, including thrombophilia, malignancy, sepsis, intra-abdominal and pelvic inflammatory conditions, pregnancy, and the postpartum period, and specific surgical interventions, particularly gynecological surgeries. Thus, this study aims to identify the associated factors for OVT and elaborate on the standard treatment strategies for its management. Methods: Retrospective data collection was used. Our study consists of 18 patients diagnosed with OVT between 2005 and 2016; the data was collected from the Health Information Management system at King Fahad Medical City, Riyadh, Saudi Arabia using a standard format. Results: . The most frequently presenting complaints were abdominal pain and fever. The most common treatment was the administration of enoxaparin (a low molecular weight heparin) for an average duration of one to three months, which resulted in a low recurrence rate of OVT. Conclusions: Physicians should be vigilant for suspicion of OVT in female patients presenting with lower abdominal pain and fever in their postpartum period. Additionally, it is suggested to use low molecular weight heparin as initial therapy for OVT for one to three months, resulting in a high remission rate.
ovarian vein thrombosislow molecular weight heparinenoxaparinpostpartum period
International Journal of General Medicine · مجلد Volume 15 · 3573-3582
Background: This is the first descriptive and comparative study conducted of COVID-19 inpatients from multi-centers in the four administrative southern regions and proposed Southern Business Unit (Jazan, Najran, Bisha, and Aseer) of the Kingdom of Saudi Arabia (KSA). Methods: Participants were 809 randomly selected patients admitted to the eight sampled hospitals with confirmed COVID-19 between March 2020 and February 2021. We assessed and compared socio-demographics, clinical characteristics, and clinical outcomes of the four regions. Results: Socio-demographic and clinical characteristics of the participants are a mean age of 60 ± 17.7 years, 70% Saudi male, the prevalence of diabetes (DM2) 58%, hypertension (HTN) 48%, obesity 43%, cardiac diseases 15%, and immunity or cancer diseases almost 1%. The prevalence of complications during admission were bacterial pneumonia 65%, acquired respiratory distress syndrome (ARDS) 32%, sepsis 20%, multi-organ failure 18%, acute kidney diseases 15%, and arrhythmia 4%. Clinical outcomes were: admitted to intensive care unit (ICU) 52%, mortality rate 25%, referred to other facilities 9%, and mean length of stay (LOS) was 11± 9.5 days. We observed statistically significant variation in many variables among the four regions. Najran and Aseer had a higher prevalence of risk factors for severity including age and comorbidities accompanied by higher rates of complications, ICU admissions, LOS, and mortality. Bisha and Jazan had lower prevalence of risk factors and LOS with lower rates of complications, ICU admissions, and mortality. Conclusion: This study reveals that the geographic region in which the patient was cared for was related to the severity and outcome of COVID-19 infection. Policy makers should search for solutions to regional differences in underlying health conditions such as DM2, HTN, and obesity to plan for improvements in preventive care as well as resource distribution to ensure quality for all Saudi citizens. This study will serve as guidance to begin to form strategies for these improvements as envisioned in the future New Model of Care.
There has been an increase in the prevalence of gram-positive bacteremia in neonates in the last two decades. However, as a consequence of better care, there has been an increase in the survival of premature neonates. Coagulase-negative staphylococci (CoNS) is the most prevalent bacteria, responsible for up to 60% of late-onset sepsis (LOS). Daptomycin, a lipopeptide antimicrobial agent, is active against CoNS. This was an observational, retrospective case series study carried out in the Pediatric Hospital of King Saud Medical City, Riyadh, Saudi Arabia. The medical records of 21 neonates, aged 0–28 days, who were treated in Neonatal Intensive Care Unit (NICU) with intravenous daptomycin as monotherapy or combination therapy for at least 4 days for proven gram-positive infection between June 2019 to July 2020, were included. The median gestational and chronological age were 27 weeks and 5 days, respectively. The most frequent diagnosis in neonates was infective endocarditis (42.9%). Of the 21 patients who received daptomycin therapy, 13 (62%) recovered and 8 died. The clinical cure rate was higher in Staphylococcus hominis (100%) and in patients who received 6 mg/kg/dose twice daily (62.5%). The mean of aspartate aminotransferase significantly elevated after starting daptomycin (p = 0.048). However, no muscular or neurological toxicity of daptomycin was documented in any of the cases. Overall, daptomycin was well tolerated, even with long-term treatment.
Infection and Drug Resistance · مجلد Volume 13 · 3843-3851
PURPOSE: We assessed the National Early Warning Score (NEWS) in emergency triage for predicting sepsis-related outcomes. METHODS: A retrospective chart review of all cases enrolled in the sepsis management protocol for a one-year duration. The protocol utilized the NEWS as a screening tool for sepsis in the triage area. Primary outcomes of interest were hyperlactatemia, admission to ICU and intrahospital mortality. Sensitivity, specificity, and area under the curve (AUC) were calculated for a given NEWS. RESULTS: A total of 444 patients were reviewed from July 2018 to June 2019, with a mean age of 58.7 years. A NEWS ≥5 was more than 88% sensitive in predicting hyperlactatemia, ICU admission, and/or mortality. Specificity, on the other hand, was as low as 12%. The AUC for the NEWS was 0.667 for predicting hyperlactatemia and 0.602 for predicting ICU admission or mortality. CONCLUSION: The NEWS was a sensitive screening tool for predicting sepsis-related outcomes. However, it was not specific, and further studies are recommended to assess the integration of other factors to improve specificity.
National Early Warning Scoresepsisemergency department triagehyperlactatemia
Journal of International Medical Research · مجلد 48 (12) · 300060520975576-300060520975576
Although rare, brucellosis is endemic in the Kingdom of Saudi Arabia (KSA). In the case presented here, a neonate was born at 29 weeks gestation with severe respiratory depression, pyrexia; hypotension and an elevated white blood cell count. Her mother was a 19-year-old pregnant woman who developed premature rupture of the membranes and went into labour early. Sepsis was suspected and so the neonate received dobutamine and empiric ampicillin/gentamicin. The mother reported visiting a farm during her pregnancy and so congenital brucellosis was considered a possibility. Blood cultures were positive for Gram-negative coccobacilli and serology confirmed the presence of Brucella abortus and B. meltiness. Antibiotic treatment was changed to rifampin/gentamicin/ciprofloxacin but on day 17 the baby deteriorated and gentamicin was discontinued and meropenem was added. The neonate gradually improved; meropenem was discontinued on day 24 and the baby was discharged from hospital on day 38.
Brucella abortusBrucella melitensisneonatal sepsispremature rupture of membranes